SIGNATURE ESTATE & INVESTMENT ADVISORS LLC
Position in GILD — Gilead Sciences, Inc.
CIK 1079935
LOS ANGELES, CA
Position in GILD
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$257,606
-$3,851 QoQ
Shares Held
2,039
+8.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,765
of 2,266 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SIGNATURE ESTATE & INVESTMENT ADVISORS LLC holds $78,743,107 across 9 Drug Manufacturers - General names. GILD ranks #9 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
57,559 | $69,037,996 | |
| 2 | JNJ |
Johnson & Johnson
|
8,972 | $2,278,618 | |
| 3 | AMGN |
Amgen Inc
|
6,232 | $2,256,731 | |
| 4 | ABBV |
AbbVie Inc.
|
5,312 | $1,336,711 | |
| 5 | AZN |
Astrazeneca PLC
|
6,802 | $1,289,794 | |
| 6 | PFE |
Pfizer Inc
|
38,803 | $934,375 | |
| 7 | MRK |
Merck & Co., Inc.
|
7,229 | $928,926 | |
| 8 | NVO |
Novo Nordisk A S
|
8,810 | $422,350 |
All Filings in GILD
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $257,606 | 2,039 | Shares | Defined | 2026-07-14 | |
| 2026-03-31 | $261,457 | 1,876 | Shares | Defined | 2026-04-15 | |
| 2025-12-31 | $222,895 | 1,816 | Shares | Defined | 2026-02-06 | |
| 2025-09-30 | $205,350 | 1,850 | Shares | Sole | 2025-11-05 | |
| No filing history on record for this holder in this stock. | ||||||